VANCOUVER, May 21, 2019 /CNW/ – Zenabis Global Inc. (TSXV:ZENA) (“Zenabis” or the “Company“) today announced the appointment of Natascha Kiernan, an experienced international finance and M&A attorney who has held senior positions at several prominent international law firms, as the newest member of its Board of Directors, effective May 20, 2019.
Ms. Kiernan’s experience includes working as Counsel in the London office of Skadden, Arps, Slate, Meagher & Flom LLP and she has represented Fortune 500 companies, financial institutions and international governments in complex corporate finance and M&A transactions totalling more than $100 billion in value and spanning six continents. In 2014, she was ranked as one of the “Top 40 Under 40 Rising Legal Stars in Europe” by the Financial News.
“We are thrilled to welcome Natascha to our board. She brings a strong legal and business background and wealth of governance experience to our board,” said Andrew Grieve, Chief Executive Officer of Zenabis. “Her knowledge, perspective and diverse skill set will complement our existing board members and be an incredible asset for our company as we advance our strategic plan.”
Ms. Kiernan holds a J.D. from Columbia University School of Law and is qualified to practice law in New York and England & Wales. She serves as an independent director on the boards of several educational and non-profit organizations.
Zenabis is a significant Canadian licensed cannabis cultivator of medical and recreational cannabis, and a propagator and cultivator of floral and vegetable products. Zenabis employs staff coast-to-coast, across facilities in Atholville, New Brunswick; Delta, Aldergrove, Pitt Meadows, and Langley, British Columbia; and Stellarton, Nova Scotia. In addition to gaining technologically advanced knowledge of plant propagation, the recent addition of state-of-the-art greenhouses in Langley, Pitt Meadows, and Aldergrove provides Zenabis with 3.5 million square feet of facility space that can, upon full conversion, be dedicated to cannabis production.
If all facility space at Zenabis Atholville, Zenabis Stellarton, Zenabis Delta, and Zenabis Langley is fully converted and dedicated to production, Zenabis will own, and have access to 660,000 square feet of high quality indoor cannabis production space, as well as 2.1 million square feet of greenhouse cannabis production space at its Langley facility, with this production strategically positioned on Canada’s coasts. Zenabis expects these facilities to have an annual design capacity of 131,300 kg of dried cannabis annually by the third quarter of 2019. These facilities, if fully built out and converted for cannabis production, would have an annual design capacity to yield approximately 478,900 kg of dried cannabis annually, for both national and international market distribution. An additional 700,000 square feet of greenhouse space will be used to continue the existing propagation business and produce industrial hemp, and can be converted to cannabis production at such a time that is beneficial to the strategic position of the company. The Zenabis brand name is used in the cannabis medical market, while the Namaste and Blazery brand names are used in the cannabis adult-use recreational market, and the True Büch brand name is used for Zenabis’ kombucha products.
Forward Looking Information
This news release contains statements that may constitute “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information may include, among others, statements regarding the future plans, costs, objectives or performance of Zenabis, or the assumptions underlying any of the foregoing. In this news release, words such as “may”, “would”, “could”, “will”, “likely”, “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate” and similar words and the negative form thereof are used to identify forward-looking statements. In this news release, forward-looking statements relate, among other things, to: facility space and facility space under, or scheduled for, construction, the expected timing and completion of current and planned conversion, expansion, licensing and optimization of our facilities and the resulting expected annual design and production capacities. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management’s good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Zenabis’ control. These risks, uncertainties and assumptions include, but are not limited to, those described in the Shelf Prospectus, a copy of which is available on SEDAR at www.sedar.com and could cause actual events or results to differ materially from those projected in any forward-looking statements. Furthermore, any forward-looking information with respect to available space for cannabis production is subject to the qualification that management of Zenabis may decide not to use all available space for cannabis production, and the assumptions that any construction or conversion would not be cost prohibitive, required permits will be obtained and the labour, materials and equipment necessary to complete such construction or conversion will be available. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Zenabis does not intend, nor undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events or circumstances or otherwise, except if required by applicable laws.
For more information, visit: https://www.zenabis.com.
SOURCE Zenabis Global Inc.
Media Relations: email@example.com, 1-844-523-8679; Investor Relations: Zenabis Global Inc., firstname.lastname@example.org, 1-844-523-8679; Andrew Grieve, Chief Executive Officer, 1-844-523-8679Copyright CNW Group 2019
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/